CollPlant Biotechnologies (CLGN) Competitors $1.82 +0.09 (+5.20%) Closing price 04:00 PM EasternExtended Trading$1.87 +0.05 (+2.75%) As of 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLGN vs. NVNO, NSPR, CTSO, MDAI, SURG, HYPR, EDAP, ICCM, MLSS, and APTShould you be buying CollPlant Biotechnologies stock or one of its competitors? The main competitors of CollPlant Biotechnologies include enVVeno Medical (NVNO), InspireMD (NSPR), Cytosorbents (CTSO), Spectral AI (MDAI), SurgePays (SURG), Hyperfine (HYPR), Edap Tms (EDAP), IceCure Medical (ICCM), Milestone Scientific (MLSS), and Alpha Pro Tech (APT). These companies are all part of the "medical equipment" industry. CollPlant Biotechnologies vs. Its Competitors enVVeno Medical InspireMD Cytosorbents Spectral AI SurgePays Hyperfine Edap Tms IceCure Medical Milestone Scientific Alpha Pro Tech CollPlant Biotechnologies (NASDAQ:CLGN) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership. Do institutionals & insiders hold more shares of CLGN or NVNO? 21.7% of CollPlant Biotechnologies shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 9.6% of CollPlant Biotechnologies shares are owned by company insiders. Comparatively, 16.0% of enVVeno Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more volatility and risk, CLGN or NVNO? CollPlant Biotechnologies has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Is CLGN or NVNO more profitable? enVVeno Medical has a net margin of 0.00% compared to CollPlant Biotechnologies' net margin of -560.92%. enVVeno Medical's return on equity of -51.32% beat CollPlant Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets CollPlant Biotechnologies-560.92% -87.33% -65.31% enVVeno Medical N/A -51.32%-48.23% Does the media favor CLGN or NVNO? In the previous week, CollPlant Biotechnologies had 2 more articles in the media than enVVeno Medical. MarketBeat recorded 3 mentions for CollPlant Biotechnologies and 1 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.89 beat CollPlant Biotechnologies' score of 0.63 indicating that enVVeno Medical is being referred to more favorably in the news media. Company Overall Sentiment CollPlant Biotechnologies Positive enVVeno Medical Very Positive Do analysts prefer CLGN or NVNO? CollPlant Biotechnologies presently has a consensus price target of $11.50, indicating a potential upside of 531.87%. Given CollPlant Biotechnologies' stronger consensus rating and higher possible upside, analysts clearly believe CollPlant Biotechnologies is more favorable than enVVeno Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CollPlant Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33enVVeno Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has higher earnings & valuation, CLGN or NVNO? CollPlant Biotechnologies has higher revenue and earnings than enVVeno Medical. enVVeno Medical is trading at a lower price-to-earnings ratio than CollPlant Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCollPlant Biotechnologies$2.47M9.36-$16.61M-$1.22-1.49enVVeno MedicalN/AN/A-$21.82M-$1.18-3.62 SummaryCollPlant Biotechnologies beats enVVeno Medical on 9 of the 16 factors compared between the two stocks. Get CollPlant Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLGN vs. The Competition Export to ExcelMetricCollPlant BiotechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$23.14M$2.93B$5.57B$9.31BDividend YieldN/A2.43%4.23%4.03%P/E Ratio-1.4920.4928.6119.73Price / Sales9.36267.08411.31174.27Price / CashN/A43.1536.0257.96Price / Book1.547.768.235.67Net Income-$16.61M-$55.11M$3.23B$257.79M7 Day Performance30.77%0.95%-0.01%0.52%1 Month Performance10.30%8.44%5.60%8.84%1 Year Performance-63.16%-2.38%26.54%14.18% CollPlant Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLGNCollPlant Biotechnologies2.378 of 5 stars$1.82+5.2%$11.50+531.9%-65.8%$23.14M$2.47M-1.4970Gap UpHigh Trading VolumeNVNOenVVeno Medical0.6347 of 5 stars$3.93-1.5%N/A-33.3%$69.97MN/A-3.3330NSPRInspireMD2.7732 of 5 stars$2.22-0.9%$4.50+102.7%-5.3%$68.62M$7.03M-2.9650High Trading VolumeCTSOCytosorbents1.5514 of 5 stars$1.03-5.5%$5.50+434.0%-3.7%$68.25M$35.33M-3.68220MDAISpectral AI3.5482 of 5 stars$2.72+1.5%$4.75+74.6%+51.9%$67.85M$29.58M-5.0483SURGSurgePays3.1661 of 5 stars$3.30+1.9%$9.00+172.7%-3.3%$66.14M$40.03M-1.1840HYPRHyperfine3.137 of 5 stars$0.77-4.4%$1.06+38.6%-24.1%$62.27M$12.89M-1.42190Positive NewsEDAPEdap Tms3.0463 of 5 stars$1.57-1.3%$8.50+441.4%-70.3%$59.45M$69.18M-2.53230News CoverageAnalyst DowngradeICCMIceCure Medical2.3193 of 5 stars$1.05-0.5%$2.50+138.1%+34.7%$58.56M$3.27M-3.7560Gap DownMLSSMilestone Scientific2.9731 of 5 stars$0.68+1.5%$1.25+83.8%-33.3%$52.58M$8.61M-9.7130Negative NewsAPTAlpha Pro Tech1.1437 of 5 stars$4.78+0.6%N/A-18.8%$51.93M$58.18M12.92120Gap Up Related Companies and Tools Related Companies enVVeno Medical Competitors InspireMD Competitors Cytosorbents Competitors Spectral AI Competitors SurgePays Competitors Hyperfine Competitors Edap Tms Competitors IceCure Medical Competitors Milestone Scientific Competitors Alpha Pro Tech Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLGN) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CollPlant Biotechnologies Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share CollPlant Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLGN Stock Alerts